BONELLO, FRANCESCA
BONELLO, FRANCESCA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?
2021-01-01 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies
2021-01-01 Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara
CD38 as an immunotherapeutic target in multiple myeloma
2018-01-01 Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F.
Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report
2021-01-01 Mina R.; Bonello F.; Gay F.; Zamagni E.; Boccadoro M.
Determining treatment intensity in elderly patients with multiple myeloma
2018-01-01 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Diagnostic and therapeutic challenges in the management of intermediate and frail elderly multiple myeloma patients
2020-01-01 Bonello F.; Boccadoro M.; Larocca A.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021-01-01 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
How is patient care for multiple myeloma advancing?
2017-01-01 Genadieva Stavric, Sonja; Bonello, Francesca; Bringhen, Sara; Boccadoro, Mario; Larocca, Alessandra
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial
2021-01-01 Mina R.; Falcone A.P.; Bringhen S.; Liberati A.M.; Pescosta N.; Petrucci M.T.; Ciccone G.; Capra A.; Patriarca F.; Rota-Scalabrini D.; Bonello F.; Musolino C.; Cea M.; Zambello R.; Tacchetti P.; Belotti A.; Cellini C.; Paris L.; Grasso M.; Aquino S.; De Paoli L.; De Sabbata G.; Ballanti S.; Offidani M.; Boccadoro M.; Monaco F.; Corradini P.; Larocca A.
Lenalidomide maintenance with or without prednisone in newly diagnosed myeloma patients: A pooled analysis
2019-01-01 Bonello F.; Pulini S.; Ballanti S.; Gentile M.; Spada S.; Annibali O.; Omede P.; Ronconi S.; Cangialosi C.; Podda L.; Palmas A.; Malfitano A.; Rivoli G.; Belotti A.; Ciambelli F.; Vincelli I.D.; Cafro A.M.; Innao V.; Palumbo A.; Sonneveld P.; Spencer A.; Hajek R.; Boccadoro M.; Gay F.
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma
2017-01-01 Salvini, Marco; Bonello, Francesca; Boccadoro, Mario; Larocca, Alessandra
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?
2021-01-01 Mina R.; Bonello F.; Oliva S.
Moving Toward Continuous Therapy in Multiple Myeloma
2019-01-01 Bonello, Francesca; Cetani, Giusy; Bertamini, Luca; Gay, Francesca; Larocca, Alessandra
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
2021-01-01 D'Agostino M.; Larocca A.; Offidani M.; Liberati A.M.; Gaidano G.; Petrucci M.T.; Derudas D.; Capra A.; Zambello R.; Cascavilla N.; de Fabritiis P.; Innao V.; Bonello F.; Patriarca F.; Benevolo G.; Giuliani N.; Aitoro G.; Guglielmelli T.; Di Raimondo F.; Corradini P.; Musto P.; Hajek R.; Sonneveld P.; Boccadoro M.; Bringhen S.
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
2022-01-01 Bonello F.; Cani L.; D'Agostino M.
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
2022-01-01 Bonello F.; Rocchi S.; Barila G.; Sandrone M.; Talarico M.; Zamagni E.; Scaldaferri M.; Vedovato S.; Bertiond C.; Pavan L.; Bringhen S.; Cattel F.; Zambello R.; Cavo M.; Mina R.
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
2022-01-01 D'Agostino, Mattia; Cairns, David A; Lahuerta, Juan José; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Mateos, María-Victoria; Dall'Olio, Daniele; van de Donk, Niels W C J; Jackson, Graham; Rocchi, Serena; Salwender, Hans; Bladé Creixenti, Joan; van der Holt, Bronno; Castellani, Gastone; Bonello, Francesca; Capra, Andrea; Mai, Elias K; Dürig, Jan; Gay, Francesca; Zweegman, Sonja; Cavo, Michele; Kaiser, Martin F; Goldschmidt, Hartmut; Hernández Rivas, Jesús María; Larocca, Alessandra; Cook, Gordon; San-Miguel, Jesús F; Boccadoro, Mario; Sonneveld, Pieter
The role of monoclonal antibodies in the first-line treatment of transplant-ineligible patients with newly diagnosed multiple myeloma
2021-01-01 Bonello F.; Grasso M.; D'agostino M.; Celeghini I.; Castellino A.; Boccadoro M.; Bringhen S.
Therapeutic monoclonal antibodies and antibody products: Current practices and development in multiple myeloma
2020-01-01 Bonello F.; Mina R.; Boccadoro M.; Gay F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? | 2021 | Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M. | |
| Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies | 2021 | Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara | |
| CD38 as an immunotherapeutic target in multiple myeloma | 2018 | Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F. | |
| Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report | 2021 | Mina R.; Bonello F.; Gay F.; Zamagni E.; Boccadoro M. | |
| Determining treatment intensity in elderly patients with multiple myeloma | 2018 | Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S. | |
| Diagnostic and therapeutic challenges in the management of intermediate and frail elderly multiple myeloma patients | 2020 | Bonello F.; Boccadoro M.; Larocca A. | |
| Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma | 2021 | Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara | |
| How is patient care for multiple myeloma advancing? | 2017 | Genadieva Stavric, Sonja; Bonello, Francesca; Bringhen, Sara; Boccadoro, Mario; Larocca, Alessandra | |
| Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial | 2021 | Mina R.; Falcone A.P.; Bringhen S.; Liberati A.M.; Pescosta N.; Petrucci M.T.; Ciccone G.; Capra A.; Patriarca F.; Rota-Scalabrini D.; Bonello F.; Musolino C.; Cea M.; Zambello R.; Tacchetti P.; Belotti A.; Cellini C.; Paris L.; Grasso M.; Aquino S.; De Paoli L.; De Sabbata G.; Ballanti S.; Offidani M.; Boccadoro M.; Monaco F.; Corradini P.; Larocca A. | |
| Lenalidomide maintenance with or without prednisone in newly diagnosed myeloma patients: A pooled analysis | 2019 | Bonello F.; Pulini S.; Ballanti S.; Gentile M.; Spada S.; Annibali O.; Omede P.; Ronconi S.; Cangialosi C.; Podda L.; Palmas A.; Malfitano A.; Rivoli G.; Belotti A.; Ciambelli F.; Vincelli I.D.; Cafro A.M.; Innao V.; Palumbo A.; Sonneveld P.; Spencer A.; Hajek R.; Boccadoro M.; Gay F. | |
| Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma | 2017 | Salvini, Marco; Bonello, Francesca; Boccadoro, Mario; Larocca, Alessandra | |
| Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time? | 2021 | Mina R.; Bonello F.; Oliva S. | |
| Moving Toward Continuous Therapy in Multiple Myeloma | 2019 | Bonello, Francesca; Cetani, Giusy; Bertamini, Luca; Gay, Francesca; Larocca, Alessandra | |
| Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score | 2021 | D'Agostino M.; Larocca A.; Offidani M.; Liberati A.M.; Gaidano G.; Petrucci M.T.; Derudas D.; Capra A.; Zambello R.; Cascavilla N.; de Fabritiis P.; Innao V.; Bonello F.; Patriarca F.; Benevolo G.; Giuliani N.; Aitoro G.; Guglielmelli T.; Di Raimondo F.; Corradini P.; Musto P.; Hajek R.; Sonneveld P.; Boccadoro M.; Bringhen S. | |
| Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting | 2022 | Bonello F.; Cani L.; D'Agostino M. | |
| Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma | 2022 | Bonello F.; Rocchi S.; Barila G.; Sandrone M.; Talarico M.; Zamagni E.; Scaldaferri M.; Vedovato S.; Bertiond C.; Pavan L.; Bringhen S.; Cattel F.; Zambello R.; Cavo M.; Mina R. | |
| Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project | 2022 | D'Agostino, Mattia; Cairns, David A; Lahuerta, Juan José; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Mateos, María-Victoria; Dall'Olio, Daniele; van de Donk, Niels W C J; Jackson, Graham; Rocchi, Serena; Salwender, Hans; Bladé Creixenti, Joan; van der Holt, Bronno; Castellani, Gastone; Bonello, Francesca; Capra, Andrea; Mai, Elias K; Dürig, Jan; Gay, Francesca; Zweegman, Sonja; Cavo, Michele; Kaiser, Martin F; Goldschmidt, Hartmut; Hernández Rivas, Jesús María; Larocca, Alessandra; Cook, Gordon; San-Miguel, Jesús F; Boccadoro, Mario; Sonneveld, Pieter | |
| The role of monoclonal antibodies in the first-line treatment of transplant-ineligible patients with newly diagnosed multiple myeloma | 2021 | Bonello F.; Grasso M.; D'agostino M.; Celeghini I.; Castellino A.; Boccadoro M.; Bringhen S. | |
| Therapeutic monoclonal antibodies and antibody products: Current practices and development in multiple myeloma | 2020 | Bonello F.; Mina R.; Boccadoro M.; Gay F. |